---
{"dg-publish":true,"permalink":"/entities/drug/ibuprofen-lysine/","tags":["drug","nsaid","pediatric","fast-acting"]}
---


# Ibuprofen Lysine

## Overview

Ibuprofen Lysine (NeoProfen) is a highly soluble form of ibuprofen. While used orally for fast pain relief, its most critical clinical application is intravenous use in the neonatal intensive care unit (NICU) to treat **Patent Ductus Arteriosus (PDA)**.

## Indications

- **Patent Ductus Arteriosus (PDA):** In premature infants.
- **Acute Pain.**
- **Migraine.**

## Relationships

TREATS_CONDITION::[[entities/condition/Patent Ductus Arteriosus\|Patent Ductus Arteriosus]]
TREATS_CONDITION::[[entities/condition/Pain\|Pain]]
ASSOCIATED_WITH_CONDITION::[[entities/condition/Premature Birth\|Premature Birth]]
INHIBITS_PROTEIN::[[COX-1\|COX-1]]
INHIBITS_PROTEIN::[[COX-2\|COX-2]]
DRUG_CONTAINS_COMPOUND::[[entities/drug/Ibuprofen\|Ibuprofen]]

## References

- FDA. NeoProfen (Ibuprofen Lysine) Injection.
- Ohlsson, A., et al. (2017). Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database of Systematic Reviews.
- MedlinePlus. Ibuprofen Lysine.
